JHI vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JHI presents a classic value trap profile, characterized by a stable Piotroski F-Score of 5/9 and significant undervaluation relative to its Graham Number ($19.68) and Intrinsic Value ($34.22). While the company boasts impressive operating margins and a low P/E ratio compared to the sector, these strengths are offset by critical liquidity concerns and an unsustainable dividend policy. The current price of $13.30 is well below fair value estimates, but the technical trend is bearish and the payout ratio exceeds 100%. Consequently, the stock is a high-yield play with significant fundamental risks regarding solvency and dividend maintenance.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
JHI vs JPM: Head-to-Head Comparison
This page compares John Hancock Investors Trust (JHI) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.